XBiotech begins patient enrollment in Phase III trial of Xilonix to treat colorectal cancer
The double-blinded, placebo controlled trial is evaluating the use of the monoclonal antibody therapy designed to block chronic inflammation associated with malignant tumor growth. According to the company,